Category

CEA/CUA

Home > Project Types > CEA/CUA

Bustamante-Balén M, Merino Rodríguez B, Barranco Priego L, Monje J, Álvarez M, de Pedro S, Oyagüez I, Van Lent N, Mareque M

 

 

Artificial intelligence-aided colonoscopy for adenoma detection and characterization. A cost-effectiveness analysis in the Spanish setting
Congreso European Society of Gastrointestinal Endoscopy (ESGE) Days. Berlín. 25-27 abr 2024

POSTER

Canut MI, García-Feijoo J, Manuel Larrosa-Poves JM, López-López F, Pazos-López M, Espinoza-Cámac N, Oyagüez I, Valor C, Del Río T, Rodríguez M

 

Análisis coste-utilidad de la emulsión catiónica de latanoprost frente a latanoprost en el tratamiento de pacientes con glaucoma en España
18º Congreso de la Sociedad Española de Glaucoma. Sevilla.07-09 mar 2024

POSTER

Buti M, Domínguez-Hernández R, Palom A, Esteban R, Casado MÁ

 

 

Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis
Liver International. 2023;43:2611–2614

MÁS INFORMACIÓN

Llaneras J, Ruiz-Cobo JC, Rando-Segura A, Barreira-Díaz A, Domínguez-Hernández R, Rodríguez-Frías F, Campins M, Colom J, Casado MA, Blanco-Grau A, Bañares J, Monforte A, Falcó A, Ruíz L, Meza B, Pumarola T, Riveiro-Barciela M, Esteban R, Buti M

 

Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination
JHEP Reports 2024 vol. 6 j 100932

Martín A, Presa M, Tejado N, Pardo C, Martín-Escudero V, Oyagüez I, Ortiz-Maldonado V

 

 

Eficiencia de axicabtagén ciloleucel en el tratamiento en segunda línea del linfoma B difuso de células grandes en España
LXV Congreso Nacional de la SEHH, XXXIX Congreso Nacional de la SETH y III Congreso Iberoamericano de Hematología. Sevilla. 26-28 oct 2023

Ortiz-Maldonado V, Presa M, Tejado N, Pardo C, Martín-Escudero V, Oyagüez I, Martín A

 

 

Axicabtagene Ciloleucel As Second-Line Treatment For Relapsed/ Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis Refractory Large B-Cell Lymphoma In Spain: A Cost-Effectiveness Analysis
26th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Copenhague (Dinamarca). 12-15 nov 2023

POSTER

Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J

 

 

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain
ClinicoEconomics and Outcomes Research. 2023:15 659–671

García Herola A, Pascual S, Cuesta R, Mármol-Aguilar C, Bejarano A, Díaz A, Millán M, Méndez M, Domínguez-Hernández R

 
 

HCV screening automation at hospitals level based on Extrahepatic Manifestations and Risk Profile. Preliminary results from the Hospitals Without_ C programme (Hospitales sin C)
International Liver Congress (EASL). Viena. 21-24 jun 2023

López-Mínguez JR, Martín de Francisco AL, Soler MJ, Hernández F, Moreno R, Pinar E, Sampedro A, Mareque M, Oyagüez I

 

 

Cost-effectiveness analysis of Dyevert™ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain
Catheter Cardiovasc Interv. 2023;102(2):233-240
1 2 3 26